糖尿病视网膜病变中的视网膜敏感度与视网膜灌注
这项前瞻性纵向队列研究在英国单中心纳入44例中重度至极重度非增殖性或增殖性糖尿病视网膜病变患者,随访至2年,评估视网膜敏感度(110°投影视野计)与视网膜灌注(超广角血管造影)的关联。基线时非灌注区敏感度缺损(11.8 dB)大于灌注区(6.6 dB),差异有统计学意义(P < .001);敏感度缺损随时间减轻,尽管血糖控制不佳且糖尿病视网膜病变分级高。
要点
- 基线时非灌注区视网膜敏感度缺损为11.8 dB,大于灌注区的6.6 dB(P < .001)。
- 仅年龄与敏感度缺损呈正相关(估计值0.2;95%CI,0.1-0.3;P = .006)。
- 灌注区中34%(711/2092)出现≥5 dB缺损,非灌注区中30%(105/354)敏感度正常。
核心结论
- 视网膜毛细血管灌注状态与功能相关,但部分灌注区出现敏感度丧失、部分非灌注区功能正常;尽管血糖控制不佳且糖尿病视网膜病变分级高,敏感度缺损随时间减轻(第一年约45%)。
研究设计与样本
- 前瞻性纵向队列研究,2018年4月18日至2024年9月9日在英国单中心开展,随访至2年,结局评估者设盲。
- 纳入年龄≥18岁、中重度至极重度非增殖性或增殖性糖尿病视网膜病变且无高危特征、至少1眼未接受过治疗、无其他视网膜疾病、能知情同意并愿意接受视网膜成像的成人。
- 共接触66人,50人符合条件并招募,最终纳入44例至少完成1次视野检查的个体;平均(SD)年龄52.1(12.2)岁,13例(29%)为女性。
- 中位血红蛋白A1c为75.5 mmol/mol(占总血红蛋白9.1%);平均(SD)最佳矫正视力字母评分为85.7(4.7)(Snellen等效20/20)。
主要发现
- 基线平均视网膜敏感度缺损与灌注状态相关:非灌注区(n = 354)为11.8 dB(95%CI,10.8-12.8),灌注区(n = 2092)为6.6 dB(95%CI,5.1-8.2),P < .001。
- 仅年龄与敏感度缺损呈正相关(估计值0.2;95%CI,0.1-0.3;P = .006)。
- 灌注区2092个中有711个(34%)出现≥5 dB缺损;非灌注区354个中有105个(30%)敏感度正常。
- 基线至1年敏感度缺损变化速率:灌注区-0.20 dB/月(95%CI,-0.24至-0.16)vs 非灌注区-0.28 dB/月(95%CI,-0.41至-0.15),灌注区 vs 非灌注区P = .22(1464个区域)。
- 基线至2年变化速率:灌注区-0.16 dB/月(95%CI,-0.20至-0.12)vs 非灌注区-0.34 dB/月(95%CI,-0.47至-0.21),灌注区 vs 非灌注区P = .007(542个区域)。
关键数值与推荐
- 原文未报告指南或共识推荐条款。
临床怎么用
- 作者认为这些发现应被考虑用于糖尿病视网膜病变患者的管理和临床试验设计。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Retinal capillary nonperfusion seems crucial in the pathogenesis of sight-threatening diabetic retinopathy (DR); currently, no treatment prevents or reverts it. OBJECTIVE: To further the understanding of the association between retinal capillary nonperfusion and sensitivity in DR. DESIGN, SETTING, AND PARTICIPANTS: This prospective, longitudinal cohort study was conducted from April 18, 2018, to September 9, 2024, at a single center in the UK. Participants were followed up for up to 2 years; outcome assessors were masked. Adults (aged ≥18 years) with moderate or severe to very severe nonproliferative or proliferative DR with less than high-risk characteristics; at least 1 eye naive to treatment; no other retinal disorders; who were able to provide informed consent; and who were willing undergo retinal imaging were eligible for inclusion. Data analysis was performed from September 2024 to April 2025. MAIN OUTCOMES AND MEASURES: The primary outcome was the association between retinal sensitivity (110° projection perimetry) and retinal perfusion (ultra-widefield angiography) at baseline and changes at 1 and 2 years in the study eye. RESULTS: Of 66 people approached, 50 were eligible and recruited, and 44 individuals with at least 1 perimetric examination were included. Mean (SD) participant age was 52.1 (12.2) years, and 13 participants (29%) were female. Median hemoglobin A1c was 75.5 mmol/mol (9.1% of total hemoglobin [to convert from percentage of total hemoglobin to proportion of total hemoglobin, multiply by 0.01]); mean (SD) best-corrected visual acuity letter score was 85.7 (4.7) (Snellen equivalent, 20/20). Mean retinal sensitivity deficit at baseline was associated with perfusion status, with larger deficits in nonperfused areas (n = 354; 11.8 dBs; 95% CI, 10.8-12.8) compared to perfused areas (n = 2092; 6.6 dB; 95% CI, 5.1-8.2; P < .001). Only age correlated positively with sensitivity deficit (estimate, 0.2; 95% CI, 0.1-0.3; P = .006). A deficit of 5 dB or greater occurred in 711 of 2092 (34%) perfused areas; 105 of 354 (30%) nonperfused areas had normal sensitivity. Rates of sensitivity deficit change in perfused and nonperfused areas from baseline to 1 year were -0.20 dB/mo (95% CI, -0.24 to -0.16) and -0.28 dB/mo (95% CI, -0.41 to -0.15) (perfused vs nonperfused, P = .22), respectively (1464 areas); from baseline to 2 years, rates were -0.16 dB/mo (95% CI, -0.20 to -0.12) and -0.34 dB/mo (95% CI, -0.47 to -0.21) (perfused vs nonperfused, P = .007), respectively (542 areas). CONCLUSIONS AND RELEVANCE: In this longitudinal cohort study, although retinal capillary perfusion status was associated with function, sensitivity loss occurred in some perfused areas and normal function in some nonperfused areas; sensitivity deficit decreased over time (approximately 45% in the first year) despite poor glycemic control and high DR grades. These findings should be considered for the management of people with DR and the design of clinical trials.
引用
- Hamilton-Perais JA, Wright DM, Lim A, et al. Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy. JAMA Ophthalmol. 2026. PMID: 41165673. doi:10.1001/jamaophthalmol.2025.3980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。